AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-20.7%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$6.67B
AUM Growth
-$4.04B
(-38%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-28.75%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
636
New
124
Increased
62
Reduced
210
Closed
196
Top Buys
| 1 |
Wells Fargo
WFC
|
$411M |
| 2 |
Citigroup
C
|
$404M |
| 3 |
ICL Group
ICL
|
$396M |
| 4 |
JPMorgan Chase
JPM
|
$394M |
| 5 |
Bank of America
BAC
|
$390M |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$2.02B |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.72B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$995M |
| 4 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
$47.5M |
| 5 |
Herbalife
HLF
|
$31.9M |
Sector Composition
| 1 | Technology | 25.43% |
| 2 | Financials | 24.6% |
| 3 | Industrials | 10.58% |
| 4 | Materials | 6.19% |
| 5 | Communication Services | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Quest Diagnostics
DGX
$20.5B
| $28K | ﹤0.01% |
212
-4,572
| -96% | -$604K |
|
327
Danaher
DHR
$143B
| $28K | ﹤0.01% |
+123
| New | +$28K |
|
|
DNB
328
DELISTED
Dun & Bradstreet
DNB
| $28K | ﹤0.01% |
1,836
-290
| -14% | -$4.42K |
|
329
Evertec
EVTC
$2.21B
| $28K | ﹤0.01% |
771
-147
| -16% | -$5.34K |
|
330
FTI Consulting
FCN
$5.46B
| $28K | ﹤0.01% |
+157
| New | +$28K |
|
331
Innoviva
INVA
$1.29B
| $28K | ﹤0.01% |
+1,874
| New | +$28K |
|
332
Labcorp
LH
$23.2B
| $28K | ﹤0.01% |
139
-29
| -17% | -$5.84K |
|
333
Premier
PINC
$2.13B
| $28K | ﹤0.01% |
784
-273
| -26% | -$9.75K |
|
|
PDCO
334
DELISTED
Patterson Companies, Inc.
PDCO
| $28K | ﹤0.01% |
930
-274
| -23% | -$8.25K |
|
335
Agilent Technologies
A
$36.5B
| $27K | ﹤0.01% |
227
-67
| -23% | -$7.97K |
|
336
ACI Worldwide
ACIW
$5.19B
| $27K | ﹤0.01% |
1,042
-74
| -7% | -$1.92K |
|
337
Encompass Health
EHC
$12.6B
| $27K | ﹤0.01% |
+598
| New | +$27K |
|
338
Evolus
EOLS
$495M
| $27K | ﹤0.01% |
+2,296
| New | +$27K |
|
339
Medtronic
MDT
$119B
| $27K | ﹤0.01% |
+303
| New | +$27K |
|
340
Marsh & McLennan
MMC
$100B
| $27K | ﹤0.01% |
171
-507
| -75% | -$80.1K |
|
341
MSCI
MSCI
$42.9B
| $27K | ﹤0.01% |
66
-9
| -12% | -$3.68K |
|
342
Option Care Health
OPCH
$4.72B
| $27K | ﹤0.01% |
+974
| New | +$27K |
|
343
Pacira BioSciences
PCRX
$1.19B
| $27K | ﹤0.01% |
469
-69
| -13% | -$3.97K |
|
344
SS&C Technologies
SSNC
$21.7B
| $27K | ﹤0.01% |
459
-30
| -6% | -$1.77K |
|
345
Visa
V
$666B
| $27K | ﹤0.01% |
138
-47
| -25% | -$9.2K |
|
|
EGRX
346
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $27K | ﹤0.01% |
617
-185
| -23% | -$8.1K |
|
|
AMK
347
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $27K | ﹤0.01% |
1,428
-231
| -14% | -$4.37K |
|
348
Baxter International
BAX
$12.5B
| $26K | ﹤0.01% |
403
-1,372
| -77% | -$88.5K |
|
349
Black Hills Corp
BKH
$4.35B
| $26K | ﹤0.01% |
+353
| New | +$26K |
|
350
Fiserv
FI
$73.4B
| $26K | ﹤0.01% |
292
-79
| -21% | -$7.03K |
|